CSTONE PHARMA-B (02616) Grants 15.7155 Million Share Options and 8.055 Million Restricted Share Units

Stock News
01/23

On January 23, 2026, the Board of Directors resolved to grant a total of 15.7155 million share options to 96 grantees under the Post-IPO Employee Share Option Scheme. Among the total of 15.7155 million share options granted, 7 million were awarded to one director, with the remaining 8.7155 million granted to the company's employees, including senior management members. On the same date, the Board also resolved to grant a total of 8.055 million Restricted Share Units (RSUs) to 88 RSU recipients under the Post-IPO Restricted Share Award Scheme. Of the total 8.055 million RSUs granted, 4.27 million were allocated to one director, while 3.785 million were awarded to the company's employees, including members of the senior management team.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10